Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haider Inam

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biorxiv : the Preprint Server for Biology|July 15, 2024
A side-by-side comparison of variant function measurements using deep mutational scanning and base editingIvan Sokirniy, Haider Inam, Marta Tomaszkiewicz, et al.
Cell Reports|March 27, 2020
Multi-scale Predictions of Drug Resistance Epidemiology Identify Design Principles for Rational Drug DesignScott M Leighow, Chuan Liu, Haider Inam, et al.
Nucleic Acids Research|July 31, 2025
A side-by-side comparison of variant function measurements using deep mutational scanning and base editingIvan Sokirniy, Haider Inam, Marta Tomaszkiewicz, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Characterizing Variants of Uncertain Drug Resistance (VUDRs) Using Quantitative Measurements at Clinical ExposuresHaider Inam, Marta Tomaszkiewicz, Joshua Reynolds, et al.
Iscience|November 26, 2021
Genomic and experimental evidence that ALK<sup>ATI</sup> does not predict single agent sensitivity to ALK inhibitorsHaider Inam, Ivan Sokirniy, Yiyun Rao, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|June 26, 2021
Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexesMickaël Marloye, Haider Inam, Connor J Moore, et al.
Nature Biotechnology|July 4, 2024
Programming tumor evolution with selection gene drives to proactively combat drug resistanceScott M Leighow, Joshua A Reynolds, Ivan Sokirniy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2020
The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoningPeter M Bruno, Mengrou Lu, Kady A Dennis, et al.
Cell Reports. Medicine|October 18, 2023
Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposingChuan Liu, Scott M Leighow, Kyle McIlroy, et al.
Inorganic Chemistry Frontiers|October 31, 2022
Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activityMickaël Marloye, Haider Inam, Connor J Moore, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|July 15, 2024
A side-by-side comparison of variant function measurements using deep mutational scanning and base editingIvan Sokirniy, Haider Inam, Marta Tomaszkiewicz, et al.
Cell Reports|March 27, 2020
Multi-scale Predictions of Drug Resistance Epidemiology Identify Design Principles for Rational Drug DesignScott M Leighow, Chuan Liu, Haider Inam, et al.
Nucleic Acids Research|July 31, 2025
A side-by-side comparison of variant function measurements using deep mutational scanning and base editingIvan Sokirniy, Haider Inam, Marta Tomaszkiewicz, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Characterizing Variants of Uncertain Drug Resistance (VUDRs) Using Quantitative Measurements at Clinical ExposuresHaider Inam, Marta Tomaszkiewicz, Joshua Reynolds, et al.
Iscience|November 26, 2021
Genomic and experimental evidence that ALK<sup>ATI</sup> does not predict single agent sensitivity to ALK inhibitorsHaider Inam, Ivan Sokirniy, Yiyun Rao, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|June 26, 2021
Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexesMickaël Marloye, Haider Inam, Connor J Moore, et al.
Nature Biotechnology|July 4, 2024
Programming tumor evolution with selection gene drives to proactively combat drug resistanceScott M Leighow, Joshua A Reynolds, Ivan Sokirniy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2020
The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoningPeter M Bruno, Mengrou Lu, Kady A Dennis, et al.
Cell Reports. Medicine|October 18, 2023
Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposingChuan Liu, Scott M Leighow, Kyle McIlroy, et al.
Inorganic Chemistry Frontiers|October 31, 2022
Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activityMickaël Marloye, Haider Inam, Connor J Moore, et al.
Pageof 2